PharmaChk, a portable device being developed to detect substandard medicines, receives $2-million grant.

Allied-Bristol Life Sciences will focus on converting university research into therapeutic candidates.

GlobalData's report looks at the growth of monoclonal antibodies in the market for acute coronary syndrome treatment.

ChargePoint Technology announced that it has acquired the assets of Forac Limited.

BioSpectra's Pennsylvania facility will manufacture biological buffers, pharmaceutical excipients, and laboratory reagents.

Metrics Contract Services adopts a more descriptive name and brand that identifies it as being part of the Mayne Pharma global family.

Acquisition of Almirall?s products will provide boost to revenue and strengthen AstraZeneca?s respiratory product line.

EMA has released the second module of a new guideline on influenza vaccines for a six-month public consultation. The guidance covers the non-clinical and clinical requirements for the development of new influenza vaccines and aims to facilitate the prompt assessment of new vaccines. It follows the publication of a module on the quality requirements.

Catalent?s $870 million IPO will help company reduce debt, enable future growth.

Hovione announced that its API plant in Cork, Ireland has successfully passed a pre-approval inspection by FDA.

A review of how mergers and acquisitions have shaped the pharmaceutical industry landscape.

Pharmaceutical Technology Europe Marks 25 years of drug-development advances.

Pfizer announced an agreement to acquire Baxter International?s marketed vaccines for $635 million.

FDA issues a warning letter to Zhejiang Jiuzhou Pharmaceutical Co., Ltd. and its import/export company for multiple CGMP violations and misbranded products.

Croda, an excipients supplier, announced that it has obtained EXCiPACT certification for its excipients manufacturing site at Mevisa, Spain.

Redbiotec and GE Healthcare Life Sciences develop a novel manufacturing process for virus-like particles.

SGS to add testing laboratories for biotechnology, extractables and leachables, and elemental impurities to Shanghai facility.

The regulatory filing marks the first step in the approval process toward making RTS,S available as an addition to existing tools currently recommended for malaria prevention.

Packaging Coordinators, Inc. expands its services with acquisition of Penn Pharmaceutical Services.

Former healthcare association executive selected to lead International Society for Pharmaceutical Engineering.

Study provides first substantive reference data on key quality attributes of empty capsules

Hospira recalls one lot of Lidocaine HCI Injection, USP, 2%, 20 mg per mL single-dose vial, preservative-free, due to particulate matter.

The president and CEO of Southern Research Institute has been named president of the Controlled Release Society.

PrimePac tubes, part of the company's new portfolio of packaging, have been specifically designed with a safety zone to hold tablet punches in position to stop damage to the tip face.

Bristol-Myers Squibb and Ono Pharmaceutical will jointly develop and commercialize immuno-oncology drugs for Japan, South Korea, and Taiwan.

European Pharmacopoeia Commission validated its strategy regarding elemental impurities and the implementation plan of the upcoming ICH Q3D guideline.

Sandoz is first to file for FDA approval of a biologic under the biosimilars pathway created in the Biologics Price Competition and Innovation Act of 2009.

CPI invests $34 million to develop a Biologics Factory of the Future due to open in 2017.